Our Pricing

Understanding Mounjaro Price Increase Costs at Cured Pharmacy

Published on: June 03, 2026

Concerned about the mounjaro price increase uk 2025? At Cured Pharmacy, we maintain transparent upfront pricing with Mounjaro available from £124.99, ensuring you know the exact cost before your free clinical consultation. As a UK-registered pharmacy (GPhC 9012511), we're committed to providing genuine UK-licensed tirzepatide with no hidden fees or surprise charges.

What's Behind the Mounjaro Price Increase UK 2025?

Pharmaceutical pricing in the UK fluctuates based on manufacturer supply agreements, regulatory changes, and market demand. Mounjaro (tirzepatide), as a relatively recent addition to the UK weight management market following MHRA approval, has seen pricing adjustments as supply chains stabilise and demand patterns emerge across private healthcare providers [1].

At Cured Pharmacy, our superintendent pharmacist Tarun Kumar (GPhC 2233073) works directly with licensed UK wholesalers to secure competitive rates. We pass these savings to patients while maintaining the rigorous clinical standards required for prescription-only medications. Every Mounjaro prescription requires assessment by a UK-registered prescriber to ensure suitability and safety.

Unlike some providers who adjust prices without notice, we display our current pricing transparently before you begin your online consultation. This approach reflects our commitment to patient trust and ensures you can make informed decisions about your weight management journey without financial surprises.

How Mounjaro Works: The Science Behind Tirzepatide

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management in the UK [1]. This dual-action mechanism distinguishes it from single-pathway treatments, activating both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously.

In the landmark SURMOUNT-1 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks, significantly outperforming placebo groups [1]. The dual receptor activation enhances insulin secretion when blood glucose is elevated, reduces glucagon secretion, slows gastric emptying, and decreases appetite through central nervous system pathways.

Clinical data from the SURMOUNT programme demonstrates that tirzepatide's effects extend beyond simple appetite suppression. Patients reported improved glycaemic control, reduced cardiovascular risk markers, and sustained weight loss when combined with lifestyle modifications including dietary changes and increased physical activity [2]. These outcomes position Mounjaro as a comprehensive metabolic intervention rather than a standalone solution.

Dosing and Administration Protocol

Mounjaro treatment begins with a 2.5mg weekly subcutaneous injection for four weeks, allowing your body to adjust to the medication. Your UK prescriber will then titrate the dose upward in 2.5mg increments every four weeks based on your response and tolerability, with maintenance doses ranging from 5mg to 15mg weekly [3].

The KwikPen delivery system simplifies self-administration with a pre-filled, single-dose injector requiring no dose preparation. Injection sites include the abdomen, thigh, or upper arm, rotated weekly to minimise injection site reactions. Patients typically report minimal discomfort with proper technique, which our clinical team reviews during your consultation.

Mounjaro Price Comparison: Understanding Your Options

When evaluating the mounjaro price increase uk market, transparency becomes essential. At Cured Pharmacy, Mounjaro starts from £124.99 depending on your prescribed dose strength. This pricing includes your medication, clinical assessment by a UK prescriber, and discreet home delivery with tracking.

Pricing variations across UK pharmacies reflect different business models, prescriber fees, and service inclusions. Some providers bundle consultation costs separately, while others include follow-up appointments or additional support services. Our model prioritises straightforward pricing—what you see during your assessment is what you pay, with no subscription lock-ins or mandatory ongoing fees.

The cost-effectiveness of Mounjaro extends beyond the immediate price point. Clinical trials demonstrate that higher efficacy rates may reduce the overall treatment duration needed to achieve target weight loss goals, potentially lowering total expenditure compared to less effective alternatives requiring longer treatment courses [1][2].

Factors Affecting Your Mounjaro Cost

Your final Mounjaro price depends on the prescribed dose strength (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, or 15mg) and the quantity of pens required per treatment cycle. Higher maintenance doses naturally cost more per pen, though many patients find optimal results at mid-range doses between 7.5mg and 10mg weekly.

Treatment duration varies individually based on weight loss goals, clinical response, and tolerability. Some patients achieve their target weight within 6-9 months, while others benefit from extended treatment courses. Your prescriber will review progress regularly and adjust treatment plans accordingly, ensuring you receive appropriate value throughout your journey.

Alternative Weight Loss Treatments at Competitive Prices

While Mounjaro represents the latest advancement in weight management pharmacotherapy, several established alternatives offer effective outcomes at different price points. Wegovy (semaglutide) utilises a single GLP-1 receptor pathway and demonstrated average weight reductions of 14.9% over 68 weeks in the STEP-1 trial [4]. As a once-weekly injection with a well-established safety profile, it remains a popular choice for UK patients.

Saxenda (liraglutide) requires daily subcutaneous injections but offers flexibility for patients preferring shorter-acting medications with more frequent dosing control. Clinical trials showed average weight loss of 8% over 56 weeks when combined with lifestyle interventions [5]. The daily administration schedule may suit individuals who prefer consistent daily routines over weekly injections.

For patients seeking non-injectable options, oral medications like Orlistat provide an alternative mechanism through lipase inhibition, reducing dietary fat absorption by approximately 30%. While generally producing more modest weight reductions (average 3-5% over 12 months), oral treatments appeal to those uncomfortable with self-injection or seeking lower-cost entry points into medical weight management [6].

Who Can Use Mounjaro? Eligibility and Safety Considerations

Mounjaro is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidaemia [3]. Your UK prescriber will calculate your BMI during the online consultation and assess whether you meet clinical criteria for prescription.

Certain medical conditions preclude Mounjaro use, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or diabetic retinopathy. Pregnant or breastfeeding individuals should not use tirzepatide, and women of childbearing potential should employ reliable contraception during treatment and for four weeks after discontinuation [3].

Common side effects include nausea, diarrhoea, vomiting, constipation, and abdominal discomfort, typically most pronounced during dose escalation phases and diminishing as treatment continues [1]. Serious but rare adverse events include pancreatitis, gallbladder disease, and hypoglycaemia (particularly when combined with other glucose-lowering medications). Your prescriber will review your complete medical history to ensure Mounjaro represents a safe, appropriate choice for your circumstances.

Contraindications and Drug Interactions

Mounjaro's effect on gastric emptying may alter the absorption of oral medications, particularly those requiring rapid onset or narrow therapeutic windows. Your prescriber will review all current medications, including over-the-counter products and supplements, to identify potential interactions requiring dose adjustments or timing modifications.

Patients taking insulin or insulin secretagogues (such as sulphonylureas) face increased hypoglycaemia risk when initiating tirzepatide. Dose reductions of these concurrent medications may be necessary, emphasising the importance of comprehensive prescriber oversight throughout treatment initiation and titration phases.

Getting Started: Your Mounjaro Journey at Cured Pharmacy

Beginning treatment takes under three minutes with our streamlined online consultation. You'll complete a confidential medical questionnaire covering your weight history, current health conditions, medications, and weight loss goals. This information allows our UK-registered prescribers to assess suitability and determine the appropriate starting dose for your individual circumstances.

If approved, your prescription is sent electronically to our dispensary where our GPhC-registered pharmacy team prepares your order. We source all Mounjaro pens directly from licensed UK wholesalers, guaranteeing authenticity and proper storage conditions. Each package includes detailed administration instructions, disposal guidance for used pens, and contact information for clinical support.

Delivery occurs in 100% discreet packaging with no external markings indicating contents. Most orders arrive within 2-3 working days via tracked courier service, allowing you to monitor your shipment in real-time. Our team remains available by phone ((+44) 116 4646009) or email throughout your treatment for questions about administration technique, side effect management, or prescription renewals.

Ongoing treatment requires periodic prescriber review to assess progress, tolerability, and continued appropriateness. We recommend tracking your weight, measurements, and any side effects in a journal to facilitate productive consultations. Your prescriber may adjust dosing, recommend treatment continuation, or discuss transition strategies once you've achieved your target weight, ensuring sustainable long-term outcomes.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-218. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2023). Two-year effects of tirzepatide on glycaemic control and body weight in participants with type 2 diabetes mellitus and obesity: 104-week results from SURMOUNT-2. Diabetes, Obesity and Metabolism, 25(11), 3184-3196. https://doi.org/10.1111/dom.15217 [accessed 13 August 2026]
3. Electronic Medicines Compendium. (2024). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14489 [accessed 13 August 2026]
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
5. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11-22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
6. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155-161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to prescribed treatment alongside lifestyle modifications including diet and exercise.